Drug profile · INN
ospemifene
SENSHIO
ospemifene (SENSHIO) is a estrogen receptor modulator. Route of administration: oral. Current US regulatory status: approved.
Drug details — ospemifene
- US status
- approved
- Class
- Genito-urinary system and sex hormones (G03)
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
ospemifene (SENSHIO) is a estrogen receptor modulator. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Estrogen receptor modulator
Primary target: Estrogen receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
| EMA | approved | — |
Related & competitor drugs
Frequently asked questions
What is ospemifene?
ospemifene (SENSHIO) is a estrogen receptor modulator. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for ospemifene?
SENSHIO is a marketed brand name for ospemifene. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of ospemifene?
ospemifene has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.